Euroimmune
| EUROIMMUN Medical Laboratory Diagnostics AG
|
|
|---|---|
 |
|
| legal form | Corporation |
| founding | 1987 |
| Seat | Lübeck , Germany |
| management | Wolfgang Schlumberger |
| Number of employees | over 3000 |
| sales | EUR 307 million |
| Branch | Laboratory diagnostics |
| Website | www.euroimmun.com |
| Status: 2018 | |
The EUROIMMUN Medical Laboratory Diagnostics AG is a German company, the reagents for medical laboratory diagnostics manufactures. The focus is on test systems that can be used to determine antibodies in the serum of patients and thus diagnose autoimmune and infectious diseases (including Covid-19 ) and allergies .
Company profile
The company was founded in September 1987 by Winfried Stöcker and is headquartered in Lübeck . Branches are located in Groß Grönau near Lübeck, in Dassow and Selmsdorf (both Mecklenburg-Western Pomerania), in Rennersdorf / OL (Saxony), in Kunnersdorf auf dem Eigen (Saxony) and in Pegnitz (Bavaria). Euroimmun has branches in China (Beijing, Hangzhou), Brazil (São Paulo), France (Bussy-Saint-Martin), Great Britain (London), Italy (Padua), Canada (Mississauga), in Poland (Wrocław), in Portugal ( Amadora), in Switzerland (Lucerne), in Singapore, in Spain (Madrid), South Africa (Cape Town), in Turkey (Istanbul) and in the USA (New Jersey) as well as a sales office in the United Arab Emirates (Dubai).
In 2017, Euroimmun had 1,800 employees in Germany and 2,575 worldwide. The group's 2017 annual turnover was EUR 284 million. According to its own information, Euroimmun employed over 2800 people in 2018, more than 2000 of them in Germany. Annual sales rose to around 307 million euros.
Biochips are one of the inventions of Euroimmun . These are paper-thin films made of glass that are coated with cells or tissue sections and then divided into millimeter-sized fragments by machine. These fragments are attached to microscope slides fully automatically. Biochip technology enables extreme miniaturization and standardization of immunobiochemical analyzes. In 1989, Euroimmun was awarded the Schmidt-Römhild Technology Prize for this process .
Euroimmun's payments of one million euros to the University of Lübeck were discontinued after a controversy between the Euroimmun founder and then chairman of the board, Winfried Stöcker, and former university president Hendrik Lehnert .
In June 2017 it was announced that the American company PerkinElmer will acquire Euroimmun. The Federal Cartel Office approved the takeover in August 2017 and the sale for 1.2 billion euros was completed on December 19, 2017.
On July 1, 2019, Wolfgang Schlumberger took over the management of the company as CEO.
Web links
Individual evidence
- ↑ | Coronavirus diagnostics
- ↑ Company profile. In: euroimmun.de. February 1, 2018, accessed August 23, 2018 .
- ↑ Thomas Stengel: A Pioneer in Medical Technology , Gadebusch-Rehnaer Zeitung, January 26, 2015
- ^ Lübeck - Winfried Stöcker: Euroimmun gives no more money for Lübeck's university. In: ln-online.de. March 11, 2015, accessed March 12, 2015 .
- ^ PerkinElmer to buy Germany's Euroimmun for about $ 1.3 billion . In: reuters.com . June 19, 2017, accessed August 8, 2017.
- ↑ Euroimmun: Green light for sales. In: Lübecker Nachrichten . August 8, 2017, p. 8.
- ↑ Perkin-Elmer Completes Acquisition of EUROIMMUN . ( businesswire.com [accessed May 7, 2018]).
- ↑ Changes in the EUROIMMUN board . ( euroimmun.de [PDF; accessed on July 1, 2019]).